Richard Youngstrom is a Senior Compliance Consultant in the Pharmaceutical industry with extensive experience (30+ years) in GMP LaboratoryCompliance and Quality System improvements. In 2013, Richard retired from his position as Director of Quality Control at Braintree Laboratories and transitioned into Pharmaceutical consulting to help pharma clients meet current regulatory guidelines and improve laboratory compliance and efficiencies; i.e. leveraging his expertise in auditing, OOS laboratory & manufacturing investigations, training, and test method optimization to gain quality efficiencies.
Mr. Youngstrom started his career with Schering Corporation in early drug discovery, and advanced through several positions to Senior Group Leader in Radiochemistry. Richard's product line experience includes radiopharmaceuticals, APIs, solid and semi-solid dose formulations, liquids, transdermal products and OTC drugs.
He is also a certified technical trainer and has conducted FDA Analyst Certification programs for a number of companies. Utilizing his ASQ CQA and CPGP certifications, he has conducted a full range of audits including clinical audits, supplier qualification, general compliance audits, and for-cause corrective action audits, within the United States and internationally.